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More than 15 years have passed since Seymour Glagov
published his seminal article describing the phenomenon of
vascular remodeling which now bears his name (1). By
meticulously examining finely sectioned left main coronary
arteries from necropsy specimens, he observed a change in
the arterial size that was proportional to the plaque burden.
This simple observation had profound implications. The
coronary arteries have always been viewed as conduits of
blood flow similar to pipes in a house. But Glagov’s
observation suggests that coronary arteries are not inanimate
pipes; instead arteries are living structures that change shape
and size to adapt to plaque accumulation. This alteration in
size, or remodeling, may effectively maintain the luminal
orifice and therefore maintain blood flow to the myocar-
dium despite the accumulation of plaque. From his and
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others’ observations, the relationship between arterial size
and plaque burden is maintained up to a plaque burden of
40% to 45% (on average), but thereafter the lumen becomes
compromised due to the inability of the artery to expand
further. The process of arterial enlargement to accommo-
date the plaque and maintain the lumen has been referred to
as the Glagov phenomenon, compensatory enlargement, or
positive remodeling.
Although the concept of vascular remodeling was revo-
lutionary, it had little effect on clinical practice in the years
immediately after its publication. By its nature (necropsy), it
was observational. It is also very difficult for an autopsy
study to discern cause from effect (i.e., was the plaque
accumulation causing the artery to expand or was plaque
accumulating in those areas because there was arterial
enlargement?). Most importantly, this phenomenon could
not be “seen” in clinical practice. Clinical assessment of
coronary arteries utilizes angiography, which outlines the
luminal contour and does not allow assessment of the plaque
nor of the true arterial size (other than by inference from the
luminal contours). If vascular remodeling could not be
confirmed in vivo and if practicing angiographers were not
able to “see” the remodeling for themselves, it would have
been a slow uphill battle before final acceptance of these
phenomena.
Intravascular ultrasound (IVUS) circumvents those limi-
tations. It allows in vivo, real-time assessment of the lumen,
plaque, and arterial (external elastic membrane [EEM])
areas. Most importantly, IVUS is performed by angiogra-
phers and allows side-by-side comparison of the angio-
graphic and ultrasound images. Immediately after inception
of IVUS in the clinical arena, it became apparent that there
is significant angiographically silent atherosclerotic disease,
in part because vascular remodeling itself is “angiographi-
cally silent.” Early IVUS studies replicated Glagov’s obser-
vations in peripheral and coronary arteries (2). In addition
to assessing the relationship between arterial size and plaque
accumulation across patients, IVUS allowed the examina-
tion of focal areas of arterial expansion associated with focal
accumulation of plaque. A remodeling index was developed
which compares the arterial area at the reference or refer-
ences to the arterial area at the lesion (3).
Intravascular ultrasound also extended the concept of
vascular remodeling beyond the Glagovian compensatory
enlargement. By comparing arterial lesion sites to adjacent
reference sites, focal luminal narrowing (or negative remod-
eling) was observed. This demonstrated that luminal steno-
sis can also be due to arterial shrinkage in addition to
atherosclerotic plaque accumulation. A remodeling index
(lesion arterial area/reference arterial area) 1 indicates
positive remodeling (enlargement), and a remodeling index
1 indicates negative remodeling. Positive remodeling has
been associated with acute (vs. stable) coronary syndromes,
and negative remodeling has been associated with smoking,
insulin-dependent diabetes, and fibro-calcific disease (4–7).
Differential remodeling in distinct populations further rein-
forces the likelihood that this phenomenon is real.
Ultimately, seeing is believing. Intravascular ultrasound
provides immediate, visual evidence to the interventional
cardiologists indicating which lesions have an arterial area
larger (or smaller) than the adjacent reference. Numerous
publications have documented patient characteristics and
clinical conditions associated with a particular type of
remodeling (4–7). Remodeling has even been reported in
arterialized saphenous vein grafts (8). Furthermore, arterial
remodeling is a dynamic phenomenon that takes place
alongside atherosclerotic plaque development, with early,
softer plaques causing positive remodeling and older, harder
plaques associated with negative remodeling (5–7). It is fair
to conclude that the process of vascular remodeling is now
well ingrained into our concept of coronary anatomy and
pathophysiology.
So why do we need yet another study on vascular
remodeling? Although the evidence is rapidly mounting to
support the concept of arterial remodeling, there remain
some very important gaps of knowledge. All too many
times, “well accepted principles” were not ultimately sup-
ported by definitive trials.
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What will it take to have definitive proof that arterial
remodeling occurs? There are at least two major areas of
deficiencies for which we need data: 1) current cross-
sectional methods of assessing remodeling assume that there
is no remodeling in the reference segment, with all the
remodeling occurring in the lesion segment; and 2) there are
virtually no longitudinal data (other than case reports or
small series [9]) demonstrating a change in arterial size in
response to a change in plaque over time.
References segment disease. While IVUS advanced our
ability to assess remodeling, it also alerted us to the diffuse
nature of plaque distribution. It is rare to have a completely
normal segment within a coronary artery. On average,
approximately 30% to 50% of the cross-sectional area of the
angiographically normal reference segment will be filled with
plaque (10). In fact, the original observations by Glagov
were in non-stenotic segments of the left main coronary
artery with diffuse disease. However, the “IVUS definition”
of remodeling (an arterial area at the reference site different
from the lesion site) assumes that the reference site is
“normal” and non-remodeled. But can the assumption be
valid or reasonable if the average reference segment is, on
average, 50% obstructed by plaque and the reference may
have also undergone remodeling? In this case, we would
only be assessing relative remodeling of the lesion compared
with that of the reference segment. The “negative remod-
eling” (lesion EEM  reference EEM) may not faithfully
describe the lesion if it is significantly influenced by positive
remodeling of the reference segment.
The study by Hong et al. (11) in this issue of the Journal
puts this vexing issue to rest. By capitalizing on a subset of
Korean patients with very little diffuse atherosclerotic dis-
ease, these investigators identified focal lesions with mini-
mal reference segment disease (mean of 14% plaque bur-
den). By including patients without substantial reference
segment disease, they avoided the potential confounding
effects of reference segment remodeling. In their subgroup,
48% demonstrated negative remodeling and 26% demon-
strated positive remodeling. The remaining 26% had “in-
termediate” remodeling (which may represent no remodel-
ing). This study provides two important aspect to our
understanding of remodeling: 1) it further supports the
concept of remodeling as a real phenomenon and proves
that remodeling is not just an “artifact” of reference segment
disease; and 2) it provides support that there is a higher
prevalence of negative remodeling than previously appreci-
ated (especially among patients with minimal atheroscle-
rotic disease in their non-lesion segments). If minimal
diffuse disease is a marker of early disease formation, this
study implies that negative remodeling may be an early
manifestation of atherosclerotic pathogenesis for (at least)
some lesions. This is opposite to conventional teaching in
which the early, soft lesions are associated with positive
remodeling and older, hard lesions with negative remodel-
ing (5–7). Consequently, as in so many other important
studies, Hong et al. (11) clarify one issue (i.e., remodeling is
not a methodological artifact) and question another conven-
tional concept (i.e., that arteries exhibit positive remodeling
early in the process of plaque formation). Unfortunately,
neither the study of Hong et al. (11) nor any other current
IVUS study can definitively address which comes first,
positive or negative remodeling. The fundamental problem
with IVUS studies to date is that they represent a cross-
sectional observation of several patients at one point in time
and infer vascular changes by comparing the lesion to the
reference segment.
The future: longitudinal IVUS studies. The time has
come to finally put this issue to rest. Direct evidence of
arterial remodeling will be available only when patients with
very early atherosclerotic disease are followed over time with
serial IVUS studies. Although this will not be easy, it is not
impossible. Several large progression/regression studies us-
ing serial IVUS examinations two years apart are ongoing to
test different pharmacologic treatment strategies. Within
these studies, there should be several arterial segments with
minimal disease that show progression. With careful align-
ment of the IVUS images, changes in arterial area (increase
in EEM) proportional to increases in the plaque area will
definitively prove the presence of positive remodeling.
These studies should also be able to demonstrate whether
early lesions more often have positive or negative remodel-
ing. Is positive versus negative remodeling a patient-specific
or lesion-specific characteristic? Does a lesion change from
one type of remodeling to another? Does the type of
remodeling in a stenotic lesion parallel the type of remod-
eling in the non-stenotic reference segment? These and
many more important aspects of remodeling need to be
addressed with longitudinal studies.
Most importantly, longitudinal studies may identify
unique patient characteristics and treatment strategies that
are associated with favorable, positive remodeling which
maintains lumen dimensions and prevents luminal obstruc-
tion. Eventually, longer term studies will be necessary to
answer important questions regarding the relationship be-
tween remodeling and patient outcomes. For example, are
lesions with positive remodeling more likely to rupture and
be associated with an acute coronary syndrome, or has that
conclusion been the result of selection bias from retrospec-
tive studies?
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